Shares of Invesco Ltd. (NYSE:IVZ – Get Free Report) have been given a consensus rating of “Hold” by the twelve brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $18.38.
IVZ has been the topic of several recent research reports. Barclays lifted their price target on Invesco from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 23rd. The Goldman Sachs Group boosted their target price on Invesco from $17.50 to $19.50 and gave the company a “neutral” rating in a research note on Wednesday, October 23rd. StockNews.com raised shares of Invesco from a “sell” rating to a “hold” rating in a research note on Friday, October 18th. Evercore ISI boosted their price objective on shares of Invesco from $18.00 to $19.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 23rd. Finally, Morgan Stanley lifted their price target on shares of Invesco from $16.00 to $17.00 and gave the company an “equal weight” rating in a research note on Friday, October 18th.
Read Our Latest Stock Report on Invesco
Invesco Stock Down 1.7 %
Invesco (NYSE:IVZ – Get Free Report) last released its earnings results on Tuesday, October 22nd. The asset manager reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. The company had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.11 billion. Invesco had a positive return on equity of 8.83% and a negative net margin of 3.00%. The firm’s quarterly revenue was down 20.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.35 earnings per share. Analysts predict that Invesco will post 1.69 earnings per share for the current year.
Invesco Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, November 14th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 4.69%. The ex-dividend date of this dividend is Thursday, November 14th. Invesco’s dividend payout ratio is currently -89.13%.
Institutional Trading of Invesco
Institutional investors and hedge funds have recently made changes to their positions in the company. Family Firm Inc. acquired a new position in shares of Invesco in the second quarter valued at approximately $28,000. Sentry Investment Management LLC acquired a new position in Invesco during the 2nd quarter valued at about $30,000. Allworth Financial LP boosted its position in shares of Invesco by 304.0% during the third quarter. Allworth Financial LP now owns 2,400 shares of the asset manager’s stock valued at $42,000 after buying an additional 1,806 shares during the last quarter. Fidelis Capital Partners LLC purchased a new stake in Invesco in the 1st quarter valued at $52,000. Finally, Abich Financial Wealth Management LLC lifted its stake in Invesco by 50.0% during the 1st quarter. Abich Financial Wealth Management LLC now owns 3,631 shares of the asset manager’s stock valued at $60,000 after acquiring an additional 1,210 shares in the last quarter. Institutional investors own 66.09% of the company’s stock.
Invesco Company Profile
Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds.
Featured Articles
- Five stocks we like better than Invesco
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Intel: Is Now the Time to Be Brave?Â
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Stock Market Upgrades: What Are They?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Invesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco and related companies with MarketBeat.com's FREE daily email newsletter.